MINATTI; Ana Elena

Patent Applications and Registrations

Patent applications and USPTO patent grants for MINATTI; Ana Elena.The latest application filed is for "kif18a inhibitors".

Company Profile

17.24.37

MINATTI; Ana Elena - SANTA MONICA CA
Minatti; Ana Elena - Thousand Oaks CA
MINATTI; Ana Elena - Los Angeles CA
- Santa Monica CA US
MINATTI; Ana Elena - Woodland Hills CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Kif18a Inhibitors App 20220289724 - TAMAYO; Nuria A. ; et al.	2022-09-15
Inhibitors Of Kras G12c And Methods Of Using The Same App 20220213101 - LANMAN; Brian Alan ; et al.	2022-07-07
Kras G12c Inhibitors And Methods Of Using The Same App 20220175782 - ALLEN; John Gordon ; et al.	2022-06-09
Inhibitors of KRAS G12C and methods of using the same Grant 11,306,087 - Lanman , et al. April 19, 2	2022-04-19
Kif18a Inhibitors App 20220106293 - TAMAYO; Nuria A. ; et al.	2022-04-07
Substituted piperazines as KRAS G12C inhibitors Grant 11,285,156 - Allen , et al. March 29, 2	2022-03-29
Macrocyclic compounds that inhibit MCL-1 protein Grant 11,279,712 - Brown , et al. March 22, 2	2022-03-22
Kif18a Inhibitors App 20220073504 - TAMAYO; NURIA A ; et al.	2022-03-10
KIF18A inhibitors Grant 11,236,069 - Tamayo , et al. February 1, 2	2022-02-01
Compounds that inhibits MCL-1 protein Grant 11,224,601 - Harrington , et al. January 18, 2	2022-01-18
KRAS G12C inhibitors and methods of using the same Grant 11,090,304 - Allen , et al. August 17, 2	2021-08-17
KRAS G12C inhibitors and methods of using the same Grant 10,988,485 - Minatti , et al. April 27, 2	2021-04-27
Compounds that inhibit Mcl-1 protein Grant 10,821,115 - Harrington , et al. November 3, 2	2020-11-03
Macrocyclic Compounds That Inhibit Mcl-1 Protein App 20200247821 - Kind Code	2020-08-06
Kif18a Inhibitors App 20200239441 - TAMAYO; Nuria A. ; et al.	2020-07-30
Inhibitors Of Kras G12c And Methods Of Using The Same App 20200207766 - LANMAN; Brian Alan ; et al.	2020-07-02
Compounds That Inhibit Mcl-1 Protein App 20200171043 - HARRINGTON; Paul E. ; et al.	2020-06-04
Inhibitors of KRAS G12C and methods of using the same Grant 10,640,504 - Lanman , et al.	2020-05-05
Compounds that inhibit Mcl-1 protein Grant 10,632,128 - Harrington , et al.	2020-04-28
Compounds That Inhibit Mcl-1 Protein App 20190381064 - HARRINGTON; Paul E. ; et al.	2019-12-19
Kras G12c Inhibitors And Methods Of Using The Same App 20190374542 - ALLEN; John Gordon ; et al.	2019-12-12
Kras G12c Inhibitors And Methods Of Using The Same App 20190345169 - MINATTI; Ana Elena ; et al.	2019-11-14
Kras G12c Inhibitors And Methods Of Using The Same App 20190343838 - Allen; John Gordon ; et al.	2019-11-14
Inhibitors Of Kras G12c And Methods Of Using The Same App 20190077801 - LANMAN; Brian Alan ; et al.	2019-03-14
Compounds That Inhibit Mcl-1 Protein App 20180289720 - Harrington; Paul E. ; et al.	2018-10-11
Amino-oxazine and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use Grant 9,777,019 - White , et al. October 3, 2	2017-10-03
Cyclopropyl Fused Thiazin-2-amine Compounds As Beta-secretase Inhibitors And Methods Of Use App 20170267673 - ALLEN; Jennifer R. ; et al.	2017-09-21
Perfluorinated cyclopropyl fused 1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use Grant 9,611,261 - Minatti , et al. April 4, 2	2017-04-04
Amino-dihydrothiazine and amino-dioxido dihydrothiazine compounds as beta-secretase antagonists and methods of use Grant 9,556,135 - Lewis , et al. January 31, 2	2017-01-31
Cyclopropyl fused thiazin-2-amine compounds as beta-secretase inhibitors and methods of use Grant 9,550,762 - Allen , et al. January 24, 2	2017-01-24
Perfluorinated Cyclopropyl Fused 1,3-oxazin-2-amine Compounds As Beta-secretase Inhibitors And Methods Of Use App 20160280695 - MINATTI; Ana Elena ; et al.	2016-09-29
Amino-Oxazine and Amino-Dihydrothiazine Compounds as Beta-Secretase Modulators and Methods of Use App 20160159818 - WHITE; Ryan ; et al.	2016-06-09
Amino-oxazine and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use Grant 9,296,759 - White , et al. March 29, 2	2016-03-29
Perfluorinated 5,6-dihydro-4H-1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use Grant 9,296,734 - Minatti , et al. March 29, 2	2016-03-29
Cyclopropyl Fused Thiazin-2-Amine Compounds as Beta-Secretase Inhibitors and Methods of Use App 20160046618 - ALLEN; Jennifer R. ; et al.	2016-02-18
Amino-dihydrothiazine And Amino-dioxido Dihydrothiazine Compounds As Beta-secretase Antagonists And Methods Of Use App 20150259308 - Lewis; Richard T. ; et al.	2015-09-17
Perfluorinated Cyclopropyl Fused 1,3-oxazin-2-amine Compounds As Beta-secretase Inhibitors And Methods Of Use App 20150252011 - Minatti; Ana Elena ; et al.	2015-09-10
Perfluorinated cyclopropyl fused 1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use Grant 9,085,576 - Minatti , et al. July 21, 2	2015-07-21
Amino-oxazines and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use Grant 9,012,446 - Chen , et al. April 21, 2	2015-04-21
Spiro-amino-imidazolone and spiro-amino-dihydro-pyrimidinone compounds as beta-secretase modulators and methods of use Grant 8,957,083 - Minatti , et al. February 17, 2	2015-02-17
Derivatives of 1 H-isoindol-3-amine, 1 H-iso-aza-indol-3amine, 3,4-dihydroisoquinolin-1-amine, and 1,4-dihydroisoquinolin-3-amine as beta-secretase inhibitors Grant 8,921,363 - Minatti , et al. December 30, 2	2014-12-30
Derivatives of 1 H-isoindol-3-amine, 1 H-iso-aza-indol-3amine, 3,4-dihydroisoquinolin-1-amine, and 1,4-dihydroisoquinolin-3-amine as beta-secretase inhibitors Grant 08921363 -	2014-12-30
Amino-Oxazine and Amino-Dihydrothiazine Compounds as Beta-Secretase Modulators and Methods of Use App 20140296226 - White; Ryan ; et al.	2014-10-02
Perfluorinated Cyclopropyl Fused 1,3-oxazin-2-amine Compounds As Beta-secretase Inhibitors And Methods Of Use App 20140275058 - MINATTI; Ana Elena ; et al.	2014-09-18
Perfluorinated 5,6-dihydro-4h-1,3-oxazin-2-amine Compounds As Beta-secretase Inhibitors And Methods Of Use App 20140249104 - MINATTI; Ana Elena ; et al.	2014-09-04
Amino heteroaryl compounds as beta-secretase modulators and methods of use Grant 8,735,384 - Paras , et al. May 27, 2	2014-05-27
Amino-dihydrothiazine And Amino-dioxido Dihydrothiazine Compounds As Beta-secretase Antagonists And Methods Of Use App 20140107109 - LEWIS; Richard T. ; et al.	2014-04-17
Amino-oxazines And Amino-dihydrothiazine Compounds As Beta-secretase Modulators And Methods Of Use App 20140045828 - CHEN; Jian ; et al.	2014-02-13
Spiro-Amino-Imidazolone and Spiro-Amino-Dihydro-Pyrimidinone Compounds as Beta-Secretase Modulators and Methods of Use App 20130338177 - Minatti; Ana Elena ; et al.	2013-12-19
Derivatives of 1H-isoindol-3-amine, 1H-iso-aza-indol-3amine, 3,4-dihydroisoquinolin-1-amine, and 1,4-dihydroisoquinolin-3-amine as Beta-secretase Inhibitors App 20130172343 - Minatti; Ana Elena ; et al.	2013-07-04
Diazaindole Inhibitors Of Crac App 20130158040 - Alam; Muzaffar ; et al.	2013-06-20
4-azaindole Inhibitors Of Crac App 20130158066 - Alam; Muzaffar ; et al.	2013-06-20
Indole Inhibitors Of Crac App 20130109720 - Alam; Muzaffar ; et al.	2013-05-02
Amino Heteroaryl Compounds as Beta-Secretase Modulators and Methods of Use App 20130040931 - Paras; Nick A. ; et al.	2013-02-14
Amino-Oxazines and Amino-Dihydrothiazine Compounds as Beta-Secretase Modulators and Methods of Use App 20110251186 - CHEN; Jian J. ; et al.	2011-10-13
Indole Derivatives As Crac Modulators App 20110071150 - Alam; Muzaffar ; et al.	2011-03-24

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.